Xbrane Biopharma AB (publ) in brief
Xbrane Biopharma AB (publ) is a listed company in the Biotechnology industry, based in Sweden. Its last known market value was $29 M (January 2024); there is no current figure. Its shares trade under the symbol XBRANE.ST (Stockholm).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Market cap history
World rank over time
Rank in Sweden: #339 (Jan 2020) · #260 (Jan 2021) · #256 (Jan 2022) · #240 (Dec 2022) · #233 (Jul 2023) · #426 (Jan 2024)
FDA drug approvals: Xbrane Biopharma AB (publ)#
1 approved applications held; 1 approvals and 0 new uses in 2026.
| Approved | Drug | Kind |
|---|---|---|
| 2026-10-27 | LucamziRanibizumab-Blrz · BLA761187 | Biologic (BLA) |
Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (XBRANE BIOPHARMA AB), so they follow acquisitions
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Xbrane Biopharma AB (publ)🇸🇪 | $29 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 15, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Xbrane Biopharma AB (publ)? Verify and update this profile — free
Show Xbrane Biopharma AB (publ)'s ranking on your website Get the badge
The badge updates itself as the ranking changes.